Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X

NCT02119754 is registered in ClinicalTrials.gov with PluroGen Therapeutics, Inc as lead sponsor.

NCT NCT02119754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02119754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Lead sponsor
PluroGen Therapeutics, Inc
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2013
Completion date
September 30, 2014
Enrollment
15 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer, infection